Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Declares $0.02 Dividend

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) announced a dividend on Tuesday, December 17th,investing.com reports. Stockholders of record on Friday, December 20th will be given a dividend of 0.019 per share by the biotechnology company on Wednesday, December 18th. This represents a dividend yield of 117.8%. The ex-dividend date is Thursday, December 19th.

Bellerophon Therapeutics Stock Performance

BLPH opened at $0.02 on Tuesday. The firm’s 50-day simple moving average is $0.04 and its 200-day simple moving average is $0.04. Bellerophon Therapeutics has a twelve month low of $0.01 and a twelve month high of $0.02. The firm has a market cap of $196,951.30, a price-to-earnings ratio of -0.02 and a beta of 0.74.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Bellerophon Therapeutics in a research report on Tuesday, December 10th. They issued a “hold” rating for the company.

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.